Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

AIMS: The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the benefits of targeting inflammation after myocardial infarction (MI). We aimed to determine whether time-to-treatment initiation (TTI) influences the beneficial impact of colchicine. METHODS AND RESULTS: In COLCOT, patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouabdallaoui, Nadia, Tardif, Jean-Claude, Waters, David D, Pinto, Fausto J, Maggioni, Aldo P, Diaz, Rafael, Berry, Colin, Koenig, Wolfgang, Lopez-Sendon, Jose, Gamra, Habib, Kiwan, Ghassan S, Blondeau, Lucie, Orfanos, Andreas, Ibrahim, Reda, Grégoire, Jean C, Dubé, Marie-Pierre, Samuel, Michelle, Morel, Olivier, Lim, Pascal, Bertrand, Olivier F, Kouz, Simon, Guertin, Marie-Claude, L’Allier, Philippe L, Roubille, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Fast Track Congress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700755/
https://www.ncbi.nlm.nih.gov/pubmed/32860034
http://dx.doi.org/10.1093/eurheartj/ehaa659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700755/
https://www.ncbi.nlm.nih.gov/pubmed/32860034
http://dx.doi.org/10.1093/eurheartj/ehaa659

Ejemplares similares